We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Technique to Repair Airway Injuries Could Apply to Other Areas of Human Body

By Biotechdaily staff writers
Posted on 28 May 2008
Tissue engineers have successfully healed airway injuries in lab rabbits using a technique they believe could apply to the trachea and other parts of the human body.

The study, published in the advance online issue of the Proceedings of the [U.S.] National Academy of Sciences (PNAS) the week of May 5, 2008, expands researchers' understanding of the control of tissue repair and could lead to new treatments for tracheal injuries, such as smoke inhalation and injury from long-term intubation.

The new method, devised by engineers from the Massachusetts Institute of Technology (Cambridge, MA, USA), heals airway injuries by placing new tracheal cells around the injury site. More...
Two types of tracheal cells, embedded within a three-dimensional (3D) gelatin scaffold, take over the functions of the damaged tissue.

"We can begin to replicate the regulatory role cells play within tissues by creating engineered constructs with more than one cell type,” said Dr. Elazer Edelman, a professor of health sciences and technology and senior author of the paper.

Patents on the technique have been licensed to Pervasis Therapeutics, Inc. (Cambridge, MA, USA), a company co-founded by Dr. Edelman, which develops cell-based therapies that induce repair and regeneration in a wide array of tissues.

The trachea and other respiratory tubes, like most tubes in the body, have an intricate, three-layer architecture. The inner layer, or epithelium, interacts with whatever is flowing through the tube, in the case of the trachea, air. The middle layer is composed of muscle that constricts or relaxes the tube, and the outer layer consists of connective tissue that supports microvessels and small nerves.

Most attempts at tissue regeneration seek to rebuild this intricate architecture with structural precision. However, the MIT researchers found that it is not necessary to recapture the ordered layering to heal injuries. Instead, they concentrated on restoring cellular health. When cells are intact and regain their biologic function, they need only reside near the injured tissue to enhance overall repair.

Dr. Edelman and colleagues accomplished this repair state by delivering a mixture of new healthy cells derived from the epithelial lining and the nourishing blood vessels. The combination of epithelial and endothelial cells take over the biochemical role lost with cell damage. The healthy cells release growth factors and other molecules necessary for healing tissue and can modulate their delivery in response to physiologic feedback control signals.

"Cells are not just an array of bricks surrounded by mortar, nor are they passive drug pumps. Cells are active elements that respond to the dynamic changes of their environment with modulated secretion of critical factors. They don't need to be stacked in one specific fashion to function, but they do need to be healthy and near the injured tissue,” said Dr. Edelman, who is also a professor at Harvard Medical School (Cambridge, MA, USA) and cardiologist at Brigham and Women's Hospital (Boston, MA, USA).

To obtain the best results, both epithelial and endothelial cells must be replaced in the injured airway. "One cell type can't do it alone. With this complex disease, each regulatory cell offers something unique and together they optimize repair,” Dr. Edelman said.

The cells must also be grown within a 3D scaffold, otherwise, the two types of cells will stay segregated and will not work as effectively. Because of the similarities between the trachea and other tubes in the body, such as those of the vascular, genitourinary, and gastrointestinal systems, the researchers believe their approach could translate to other organs. "We can apply this same approach to so many different parts of the body,” said Dr. Brett Zani, a postdoctoral associate in the Harvard-MIT Division of Health Sciences and Technology and lead author of the study.


Related Links:
Massachusetts Institute of Technology
Pervasis Therapeutics

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.